Ingalls & Snyder LLC Concert Pharmaceuticals, Inc. Transaction History

Ingalls & Snyder LLC

$2.56 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$4.34 - $5.84 $150,164 - $202,064	-34,600 Reduced 2.6%	1,295,833 $7.57 Million
Q3 2022 Oct 21, 2022	SELL	$4.27 - $7.2 $344,674 - $581,184	-80,720 Reduced 5.72%	1,330,433 $8.91 Million
Q2 2022 Aug 11, 2022	BUY	$2.8 - $6.36 $262,444 - $596,122	93,730 Added 7.11%	1,411,153 $5.94 Million
Q1 2022 May 09, 2022	SELL	$2.73 - $3.94 $112,339 - $162,131	-41,150 Reduced 3.03%	1,317,423 $4.44 Million
Q4 2021 Feb 11, 2022	SELL	$2.69 - $4.22 $1.06 Million - $1.66 Million	-394,331 Reduced 22.5%	1,358,573 $4.28 Million
Q3 2021 Oct 27, 2021	BUY	$3.17 - $4.15 $76,092 - $99,616	24,004 Added 1.39%	1,752,904 $5.73 Million
Q2 2021 Aug 03, 2021	BUY	$3.77 - $5.24 $1.04 Million - $1.44 Million	274,925 Added 18.91%	1,728,900 $7.3 Million
Q1 2021 Apr 21, 2021	BUY	$4.86 - $13.07 $446,011 - $1.2 Million	91,772 Added 6.74%	1,453,975 $7.26 Million
Q4 2020 Jan 27, 2021	SELL	$9.48 - $12.84 $13,272 - $17,976	-1,400 Reduced 0.1%	1,362,203 $17.2 Million
Q3 2020 Oct 21, 2020	SELL	$8.67 - $10.82 $159,918 - $199,574	-18,445 Reduced 1.33%	1,363,603 $13.4 Million
Q2 2020 Jul 31, 2020	SELL	$7.8 - $11.52 $575,359 - $849,761	-73,764 Reduced 5.07%	1,382,048 $13.8 Million
Q1 2020 Apr 22, 2020	SELL	$5.98 - $13.09 $59,202 - $129,591	-9,900 Reduced 0.68%	1,455,812 $12.9 Million
Q4 2019 Jan 15, 2020	SELL	$5.71 - $9.22 $377,716 - $609,903	-66,150 Reduced 4.32%	1,465,712 $13.5 Million
Q3 2019 Oct 16, 2019	BUY	$5.88 - $12.35 $1.01 Million - $2.13 Million	172,487 Added 12.69%	1,531,862 $9.01 Million
Q2 2019 Jul 11, 2019	BUY	$9.44 - $13.12 $1.7 Million - $2.37 Million	180,400 Added 15.3%	1,359,375 $16.3 Million
Q1 2019 Apr 11, 2019	SELL	$12.07 - $17.54 $24,140 - $35,080	-2,000 Reduced 0.17%	1,178,975 $14.2 Million
Q4 2018 Jan 24, 2019	SELL	$11.25 - $16.17 $1.82 Million - $2.62 Million	-162,000 Reduced 12.06%	1,180,975 $14.8 Million
Q3 2018 Oct 24, 2018	BUY	$12.82 - $17.88 $65,548 - $91,420	5,113 Added 0.38%	1,342,975 $19.9 Million
Q2 2018 Aug 10, 2018	BUY	$16.83 - $21.66 $265,914 - $342,228	15,800 Added 1.2%	1,337,862 $22.5 Million
Q1 2018 Apr 17, 2018	BUY	$19.24 - $28.03 $144,300 - $210,225	7,500 Added 0.57%	1,322,062 $30.3 Million
Q4 2017 Jan 19, 2018	BUY	$13.96 - $29.05 $1.47 Million - $3.06 Million	105,500 Added 8.73%	1,314,562 $34 Million
Q3 2017 Oct 20, 2017	BUY	$13.91 - $15.31 $16.8 Million - $18.5 Million	1,209,062	1,209,062 $17.8 Million

Others Institutions Holding CNCE

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About CONCERT PHARMACEUTICALS, INC.

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

More about CNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.

Account